Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Alifrangis, C.
89  Ergebnisse:
OpenAccess-Volltexte X
Personensuche X
?
1

Seminoma and dysgerminoma: evidence for alignment of clinic..:

Wood, GE ; Bunting, CP ; Veli, M...
Front Oncol.  , 2023
Link: https://qmro.qmul.ac.uk/..
 
?
2

The potential of using circulating tumour cells and their g..:

Davies, CR ; Guo, T ; Burke, E...
Frontiers in Oncology.  , 2023
Link: https://qmro.qmul.ac.uk/..
 
?
3

Management of stage II seminoma: a contemporary UK perspect..:

Alifrangis, C ; Nicol, DL ; Shamash, J.
SCOTTISH MEDICAL JOURNAL.  , 2022
Link: https://qmro.qmul.ac.uk/..
 
?
4

The impact of a supranetwork multidisciplinary team (SMDT) ..:

Shamash, J ; Ansell, W ; Alifrangis, C...
issn:0007-0920.  , 2021
Link: http://hdl.handle.net/11..
 
?
5

The Identification of Plasma Exosomal miR-423-3p as a Poten..:

Guo, T ; Wang, Y ; Jia, J...
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY.  , 2021
Link: https://qmro.qmul.ac.uk/..
 
?
6

Neutropenic sepsis rates in patients receiving BEP chemothe..:

Gjafa, E ; Ng, K ; Grunewald, T...
https://discovery.ucl.ac.uk/id/eprint/10105324/3/Ng_Febrile%20neutropenia%20Olanzapine%20paper%20CLEAN.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
7

Febrile neutropenia (FN) rates in metastatic hormone sensit..:

Pemberton, L ; Ng, K ; McGovern, U...
https://discovery.ucl.ac.uk/id/eprint/10106301/3/Ng_Febrile%20neutropenia%20%28FN%29%20rates%20in%20metastatic%20hormone%20sensitive%20prostate%20cancer_AAM.pdf.  , 2021
Link: https://discovery.ucl.ac..
 
?
8

The Use of Transdermal Estrogen in Castrate-resistant, Ster..:

Smith, K ; Galazi, M ; Openshaw, MR...
https://discovery.ucl.ac.uk/id/eprint/10097297/8/Sarker_CGUC-D-19-00212R1_segment.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
9

Dose dense chemotherapy for untreated poor prognosis and re..:

Shamash, J ; Mee, M ; Sarker, S-J...
https://discovery.ucl.ac.uk/id/eprint/10088819/1/bju.14947.pdf.  , 2020
Link: https://discovery.ucl.ac..
 
?
10

The management of patients with learning difficulties and t..:

Mott, CE ; Ng, K ; Alifrangis, C
https://discovery.ucl.ac.uk/id/eprint/10112064/3/Ng_BMJ%20case%20report%20KN%2015.09.2019.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
11

Molecular and histopathology directed therapy for advanced ..:

Alifrangis, C ; McGovern, U ; Freeman, A..
https://discovery.ucl.ac.uk/id/eprint/10097059/1/Alifrangis_2019_Final%20edits.pdf.  , 2019
Link: https://discovery.ucl.ac..
 
?
12

Dose intense chemotherapy in the management of poor prognos..:

Ng, K ; Duncan, S ; Shamash, J.
https://discovery.ucl.ac.uk/id/eprint/10099698/3/Ng_Dose%20intense%20chemotherapy%20in%20the%20management%20of%20poor%20prognosis%20and%20relapsed%20testicular%20cancer_AAM.pdf.  , 2018
Link: https://discovery.ucl.ac..
 
?
13

Loss of functional BAP1 augments sensitivity to TRAIL in ca..:

Kolluri, KK ; Alifrangis, C ; Kumar, N...
https://discovery.ucl.ac.uk/id/eprint/10042318/1/elife-30224-v2.pdf.  , 2018
Link: https://discovery.ucl.ac..
 
?
14

Assessing tumor molecular profiling to guide treatments for..:

Carter, P ; Alifrangis, C ; Cereser, B...
Oncotarget.  , 2017
Link: http://hdl.handle.net/10..
 
?
15

Comprehensive Pharmacogenomic Profiling of Malignant Pleura..:

Quispel-Janssen, JM ; Badhai, J ; Schunselaar, L...
https://discovery.ucl.ac.uk/id/eprint/10042828/1/Kolluri_Comprehensive%20pharmacogenomic%20profiling%20of%20malignant%20pleural.pdf.  , 2017
Link: https://discovery.ucl.ac..
 
1-15